BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30241002)

  • 21. Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.
    Tsimberidou AM; Ringborg U; Schilsky RL
    Am Soc Clin Oncol Educ Book; 2013; ():118-25. PubMed ID: 23714475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The European Cancer Patient Coalition and its central role in connecting stakeholders to advance patient-centric solutions in the mission on cancer.
    de Lorenzo F; Apostolidis K
    Mol Oncol; 2019 Mar; 13(3):653-666. PubMed ID: 30657631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partnering with patients in translational oncology research: ethical approach.
    Mamzer MF; Duchange N; Darquy S; Marvanne P; Rambaud C; Marsico G; Cerisey C; Scotté F; Burgun A; Badoual C; Laurent-Puig P; Hervé C
    J Transl Med; 2017 Apr; 15(1):74. PubMed ID: 28390420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enabling personalized medicine in Europe by the European Commission's funding activities.
    Nimmesgern E; Norstedt I; Draghia-Akli R
    Per Med; 2017 Jul; 14(4):355-365. PubMed ID: 29749834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluation.
    Coebergh JW; van den Hurk C; Rosso S; Comber H; Storm H; Zanetti R; Sacchetto L; Janssen-Heijnen M; Thong M; Siesling S; van den Eijnden-van Raaij J
    Eur J Cancer; 2015 Jun; 51(9):997-1017. PubMed ID: 25956208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practice innovation: the need for nimble data platforms to implement precision oncology care.
    Elfiky A; Zhang D; Krishnan Nair HK
    Discov Med; 2015; 20(108):27-32. PubMed ID: 26321084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality-assured research environments for translational cancer research.
    Berns A
    Mol Oncol; 2019 Mar; 13(3):543-548. PubMed ID: 30628170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe.
    Rossi E; Vita A; Baccetti S; Di Stefano M; Voller F; Zanobini A
    Support Care Cancer; 2015 Jun; 23(6):1795-806. PubMed ID: 25471177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Policy statement on multidisciplinary cancer care.
    ; Borras JM; Albreht T; Audisio R; Briers E; Casali P; Esperou H; Grube B; Hamoir M; Henning G; Kelly J; Knox S; Nabal M; Pierotti M; Lombardo C; van Harten W; Poston G; Prades J; Sant M; Travado L; Valentini V; van de Velde C; van den Bogaert S; van den Bulcke M; van Hoof E; van den Neucker I; Wilson R
    Eur J Cancer; 2014 Feb; 50(3):475-80. PubMed ID: 24321260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper.
    Aapro M; Astier A; Audisio R; Banks I; Bedossa P; Brain E; Cameron D; Casali P; Chiti A; De Mattos-Arruda L; Kelly D; Lacombe D; Nilsson PJ; Piccart M; Poortmans P; Riklund K; Saeter G; Schrappe M; Soffietti R; Travado L; van Poppel H; Wait S; Naredi P
    Eur J Cancer; 2017 Sep; 82():193-202. PubMed ID: 28692951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alliance Against Cancer, the network of Italian cancer centers bridging research and care.
    De Paoli P; Ciliberto G; Ferrarini M; Pelicci P; Dellabona P; De Lorenzo F; Mantovani A; Musto P; Opocher G; Picci P; Ricciardi W; De Maria R
    J Transl Med; 2015 Nov; 13():360. PubMed ID: 26578263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on 'preclinical and early-phase clinical pharmacology'.
    Leonetti A; Boyd L; Giuliani J; Giovannetti E; Garajová I
    Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1033-1036. PubMed ID: 31633383
    [No Abstract]   [Full Text] [Related]  

  • 34. Challenges for children and adolescents with cancer in Europe: the SIOP-Europe agenda.
    Vassal G; Fitzgerald E; Schrappe M; Arnold F; Kowalczyk J; Walker D; Hjorth L; Riccardi R; Kienesberger A; Jones KP; Valsecchi MG; Janic D; Hasle H; Kearns P; Petrarulo G; Florindi F; Essiaf S; Ladenstein R
    Pediatr Blood Cancer; 2014 Sep; 61(9):1551-7. PubMed ID: 24706509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Integrating China in the International Consortium for Personalized Medicine": The Coordination and Support Action to Foster Collaboration in Personalized Medicine Development between Europe and China.
    Morsella A; Cadeddu C; Castagna C; Hoxhaj I; Sassano M; Wang CM; Wang L; Klessova S; de Belvis AG; Boccia S; Ricciardi W
    Public Health Genomics; 2021; 24(5-6):310-314. PubMed ID: 34392247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
    Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of precision medicine in healthcare-A European perspective.
    Stenzinger A; Moltzen EK; Winkler E; Molnar-Gabor F; Malek N; Costescu A; Jensen BN; Nowak F; Pinto C; Ottersen OP; Schirmacher P; Nordborg J; Seufferlein T; Fröhling S; Edsjö A; Garcia-Foncillas J; Normanno N; Lundgren B; Friedman M; Bolanos N; Tatton-Brown K; Hill S; Rosenquist R
    J Intern Med; 2023 Oct; 294(4):437-454. PubMed ID: 37455247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalized Medicine: What's in it for Rare Diseases?
    Schee Genannt Halfmann S; Mählmann L; Leyens L; Reumann M; Brand A
    Adv Exp Med Biol; 2017; 1031():387-404. PubMed ID: 29214584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precision Medicine: From Science To Value.
    Ginsburg GS; Phillips KA
    Health Aff (Millwood); 2018 May; 37(5):694-701. PubMed ID: 29733705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.